Selecting a qualified Semax injection manufacturer requires rigorous quality control standards, transparent lot verification, and documented peptide purity. PX1 Research synthesizes high-purity, laboratory-grade Semax for in vitro and preclinical research applications, delivering fully characterized compounds backed by ISO 17025 third-party analytical testing.
Selecting a qualified Semax injection manufacturer requires rigorous quality control standards, transparent lot verification, and documented peptide purity. PX1 Research synthesizes high-purity, laboratory-grade Semax for in vitro and preclinical research applications, delivering fully characterized compounds backed by ISO 17025 third-party analytical testing.
A reliable Semax injection manufacturer must adhere to strict peptide synthesis protocols, precise sequence validation, and comprehensive purity testing. When evaluating suppliers for laboratory supply, researchers require complete batch traceability, low endotoxin thresholds, and reliable analytical verification to ensure experimental consistency across non-human models.
PX1 Research manufactures research-grade peptides in US-based, cGMP-compliant facilities. Every batch of our Semax research peptides undergoes dual High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing in an ISO 17025 accredited laboratory. Designed exclusively for laboratory research use only, our formulations fulfill the demanding consistency requirements of institutional research, academic investigations, and high-throughput drug development assays.
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone, specifically ACTH(4-10). It possesses the primary amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. By stabilizing the native sequence with a C-terminal Pro-Gly-Pro tripeptide, peptide chemists significantly enhance resistance to enzymatic degradation by serum endopeptidases.
This structural modification dramatically extends the biological half-life of the compound during in vitro cellular assays and rodent model evaluations compared to native ACTH fragments. Understanding these structural properties allows primary investigators to calculate precise peptide stability metrics when designing longitudinal protocols in neurotrophic pathway assays.
The molecular weight of Semax is approximately 810.9 shift Da, with a defined chemical formula of C37H51N9O10S. Synthetic production requires solid-phase peptide synthesis (SPPS) using Fmoc chemistry, followed by reverse-phase chromatographic purification to remove incomplete peptide fragments, truncated sequences, and residual organic solvents.
In preclinical literature, Semax is primarily characterized as a regulatory peptide analog with profound effects on neurotrophic expression. Preclinical studies suggest that exposure to Semax triggers a rapid increase in brain-derived neurotrophic factor (BDNF) gene expression and protein levels within mammalian central nervous system tissues.
In vitro data indicate that Semax upregulates the transcription of tropomyosin receptor kinase B (TrkB)—the primary receptor target for BDNF signaling—thereby accelerating intracellular cascades such as the MAPK/ERK and PI3K/Akt pathways. Researchers studying neuronal survival, dendritic arborization, and synaptic plasticity frequently use Semax to modulate these target signaling pathways.
Furthermore, preclinical research demonstrates that Semax influences nerve growth factor (NGF) mRNA expression, particularly in hippocampal and cortical structures. Investigating these neurotrophic interactions helps clarify how synthetic regulatory peptides influence cellular adaptation during exposure to chemical or ischemic stimuli.
Beyond BDNF expression, animal models have shown that Semax alters cellular responses to acute and chronic neurological stress. Preclinical studies suggest that administration of Semax in rodent models of focal cerebral ischemia modulates inflammatory gene expression, decreasing the transcription of pro-inflammatory cytokines such as IL-6 and TNF-alpha while supporting vascular endothelial growth factor (VEGF) signaling.
In vitro research on cultured primary neurons shows that exposure to Semax protects against excitotoxic cell death induced by elevated glutamate concentrations. The peptide appears to stabilize mitochondrial membrane potential and limit reactive oxygen species (ROS) accumulation during severe hypoxia assays.
Additionally, transcriptome profiling in animal models indicates that Semax rapidly alters the expression of genes governing neurotransmitter systems, specifically dopaminergic and serotonergic signaling networks. This broad regulatory capacity makes Semax a vital tool for investigators exploring neuroprotection, cerebrovascular regulation, and stress response mechanisms.
When designing neurobiological and regulatory peptide experiments, researchers often evaluate Semax alongside other prominent central nervous system research compounds, such as Selank and Dihexa. While all three peptides are investigated for neurotrophic and neuroprotective properties, their molecular targets and structural lineages differ significantly.
Semax is an ACTH(4-10) analog focused heavily on BDNF/TrkB stimulation and vascular endothelial response under hypoxic stress. In contrast, Selank is a synthetic analog of the immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro), studied primarily for its interaction with the GABAergic system, enkephalin degradation inhibition, and cytokine modulation during stress responses.
Meanwhile, Dihexa is an oligopeptide derivative designed as an ultra-high-affinity hepatocyte growth factor (HGF) ligand, acting through the c-Met receptor pathway to promote spinogenesis and synaptogenesis at picomolar concentrations. Researchers seeking a broader catalog of cognitive and neurological research molecules can explore our complete PX1 Research product catalog or consult our detailed review of nootropic peptide mechanisms.
Sourcing peptides from an unverified manufacturer poses severe risks to empirical data integrity. Unpurified or contaminated peptide reagents can introduce structural batch variability, trace heavy metals, residual trifluoroacetic acid (TFA), or bacterial endotoxins that compromise cellular assays and confound rodent model data.
At PX1 Research, every single lot produced by our Semax injection manufacturing facilities undergoes independent, third-party laboratory verification. Our quality control parameters mandate:
- **Purity Verification:** High-Performance Liquid Chromatography (HPLC) verifying ≥99% target peptide purity. - **Mass Identification:** Electrospray Ionization Mass Spectrometry (ESI-MS) confirming exact molecular mass and sequence identity without truncated impurities. - **Endotoxin Testing:** Chromogenic LAL assay ensuring endotoxin levels remain below 0.5 EU/mg, preventing unwanted inflammatory artifacts in cell cultures or preclinical subjects. - **Lot Traceability:** Transparency via accessible, lot-specific Certificates of Analysis (COAs) attached directly to each product shipment.
By enforcing these strict release criteria, PX1 Research provides primary investigators with consistent, fully validated chemical compounds designed specifically for reproducible laboratory experimentation.
To preserve the structural integrity of lyophilized Semax during handling and storage, laboratory personnel must adhere to standardized biochemical protocols. Lyophilized Semax should be stored at -20°C upon receipt for long-term stability, protected from light and moisture.
When preparing stock solutions for in vitro or animal model research, reconstitution should occur in an aseptic environment (such as a Class II laminar flow hood) using Sterile Bacteriostatic Water or standard Phosphate-Buffered Saline (PBS, pH 7.4).
**Standard Reconstitution Guidelines for Laboratory Use:** 1. Allow the lyophilized vial to equilibrate to room temperature prior to reconstitution to avoid condensation moisture. 2. Gently inject the designated volume of diluent along the inner glass wall of the vial using a sterile syringe. 3. Swirl the vial gently until the cake is fully dissolved. Never vortex high-purity peptides, as mechanical shear stress can denature delicate peptide chains. 4. Aliquot the reconstituted solution into sterile microcentrifuge tubes to prevent repeated freeze-thaw cycles. 5. Store reconstituted liquid aliquots at 2°C to 8°C for short-term assays (up to 30 days) or -80°C for extended experimental timelines.
PX1 Research supports university laboratories, contract research organizations (CROs), and biotechnology enterprises with reliable, scalable supply solutions. Whether conducting exploratory in vitro screenings or executing large-scale animal study cohorts, our supply chain ensures consistent batch production and immediate fulfillment.
Orders placed Monday through Friday ship same-day from our dual fulfillment centers in California and Arizona. For high-volume institutional purchasing, specialized custom synthesis, or recurring bulk shipments, researchers can register directly through the PX1 wholesale portal or browse our extensive peer-reviewed documentation in the research resource library.
What is Semax and how is it classified in laboratory research?
Semax is a synthetic heptapeptide derived from an ACTH(4-10) fragment with a C-terminal Pro-Gly-Pro sequence. It is classified strictly as a regulatory peptide analog studied in preclinical research models for neurotrophic signaling, BDNF upregulation, and cellular stress adaptation.
What purity levels are guaranteed by PX1 Research for Semax?
PX1 Research guarantees a minimum purity of 99% for all Semax lots, verified by RP-HPLC and Mass Spectrometry. Every lot includes a third-party Certificate of Analysis (COA) confirming analytical compliance.
How does PX1 Research test for bacterial endotoxins?
Every batch undergoes rigorous Limulus Amebocyte Lysate (LAL) testing conducted by an independent ISO 17025 accredited laboratory to ensure endotoxin limits remain under 0.5 EU/mg, preventing cellular toxicity and unwanted immune responses in preclinical models.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in cGMP-compliant facilities located in the USA. Orders ship same-day (Monday through Friday) from our fulfillment facilities in California and Arizona.
How should lyophilized Semax be stored upon delivery?
Lyophilized Semax should be kept at -20°C for long-term storage, shielded from light and humidity. Once reconstituted, stock solutions should be aliquoted and stored at 2°C–8°C for short-term research or -80°C for extended protocol schedules.
What diluents are recommended for reconstituting Semax for research use?
For in vitro cellular assays and rodent model preparation, sterile 0.9% sodium chloride, sterile bacteriostatic water, or phosphate-buffered saline (PBS, pH 7.4) are standard diluents. Reconstitution should always take place under a sterile laminar flow hood.
Can Semax be purchased for clinical or personal human use?
No. All products sold by PX1 Research, including Semax, are strictly formulated and labeled for laboratory research use only (RUO). They are explicitly not intended for human consumption, therapeutic treatment, clinical diagnosis, or veterinary application.
What primary receptor pathways are investigated with Semax in preclinical trials?
Preclinical investigations primarily focus on the upregulation of BDNF and NGF gene expression, binding affinity for TrkB neurotrophin receptors, modulation of vascular endothelial growth factor (VEGF), and transcriptional changes in central dopaminergic and serotonergic receptors.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.